Health
Mounjaro and Zepbound: The Case for Two Hormones at Once
Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024

Search
27 stories for“how to choose a regulator”
Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024

Over-the-counter glucose monitors reached healthy consumers in 2024, but research suggests their readings may not mean what wearers assume.
Jul 22, 2025
